Together Pharma Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Together Pharma.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Interactive Media and Services earnings growth13.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues

Nov 04
Market Cool On Together Pharma Ltd's (TLV:TGTR) Revenues

Is Together Pharma (TLV:TGTR) A Risky Investment?

Sep 13
Is Together Pharma (TLV:TGTR) A Risky Investment?

Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

Aug 02
Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

May 31
Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

Apr 04
Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Dec 28
A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Returns At Together Pharma (TLV:TGTR) Are On The Way Up

Nov 13
Returns At Together Pharma (TLV:TGTR) Are On The Way Up

Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Oct 09
Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Sep 03
Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Sep 03
Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

May 27
Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Jan 05
Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

Oct 28
Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Sep 03
Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

Jul 29
Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

Apr 08
Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

Dec 24
Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Together Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TASE:TGTR - Analysts future estimates and past financials data (ILS Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202496-31113N/A
3/31/202493-31214N/A
12/31/202391-41415N/A
9/30/202379-9910N/A
6/30/202367-1445N/A
3/31/202349-24-5-4N/A
12/31/202231-34-14-14N/A
9/30/202223-29-15-14N/A
6/30/202216-23-19-19N/A
3/31/202214-19-16-15N/A
12/31/202112-14-20-19N/A
9/30/202114-14-25-20N/A
6/30/202113-2-25-10N/A
3/31/2021137-28-12N/A
12/31/2020117-29-10N/A
9/30/202079-27-8N/A
6/30/20204-2-26-12N/A
3/31/20201-12-27-11N/A
12/31/2019N/A-15-23-7N/A
9/30/2019N/A-15-27-9N/A
6/30/2019N/A-15-31-10N/A
3/31/2019N/A-82-25-8N/A
12/31/2018N/A-150-19-5N/A
9/30/2018N/A-147-11-4N/A
6/30/2018N/A-144-4-2N/A
3/31/2018N/A-72N/A-1N/A
12/31/2017N/A0N/AN/AN/A
9/30/2017-2-1N/A-1N/A
6/30/2017-2-1N/A-2N/A
3/31/2017-2-2N/A-2N/A
12/31/2016N/A-2N/A-3N/A
9/30/20166-1N/A-2N/A
6/30/20168-2N/A-2N/A
3/31/201611-1N/A-4N/A
12/31/2015N/A-4N/A-4N/A
9/30/201512-2N/A-5N/A
6/30/201511-3N/A-5N/A
3/31/201510-5N/A-2N/A
12/31/20148-5N/A-3N/A
9/30/20145-6N/A-3N/A
6/30/20143-6N/A-3N/A
3/31/20141-4N/A-4N/A
12/31/20131-4N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if TGTR's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if TGTR's earnings are forecast to grow faster than the IL market

High Growth Earnings: Insufficient data to determine if TGTR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if TGTR's revenue is forecast to grow faster than the IL market.

High Growth Revenue: Insufficient data to determine if TGTR's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TGTR's Return on Equity is forecast to be high in 3 years time


Discover growth companies